Oria Bioscience

📍 Paris, France🗓 Founded 2024👥 10 employees💰 Last funded Mar 2025
Biotechnology Research
LinkedIn
Oria Bioscience is a pioneering French TechBio company expert in generating organelles. We deliver high-quality, intact living organelles, surrounded by their therapeutic membrane targets. For the first time, organelles are being distributed globally and are fully compatible with high-throughput screening campaigns and drug development efforts. Thanks to our microfluidics technology, we supply pharmaceutical laboratories and CROs with purified organelles (lysosomes, mitochondria, and endoplasmic reticulum). Working directly with organelles improves efficacy results, reduces attrition rates in clinical phases, accelerates Hit-to-Lead and Lead Optimization phases, and minimizes your carbon footprint by reducing resources used. Oria’s team brings together over 50 years of expertise in organelles and microfluidics, dedicated to delivering organelles worldwide to meet drug discovery needs. We are making organelles as accessible as cells, driving innovation across all health sectors.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Oria Bioscience?
Oria Bioscience has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Oria Bioscience last raise funding?
The most recent investment in Oria Bioscience recorded on gritt.io was in March 2025.
When was Oria Bioscience founded?
Oria Bioscience was founded in 2024.
What industry is Oria Bioscience in?
Oria Bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oria Bioscience based?
Oria Bioscience is headquartered in Paris, France.